| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Sitagliptin Phosphate | FAERS: 6 | US FAERS | |
| 2 | Imatinib Mesylate | FAERS: 2 | US FAERS | |
| 3 | Sorafenib | FAERS: 2 | US FAERS | |
| 4 | regorafenib | FAERS: 2 | US FAERS | |
| 5 | Aspirin-oxycodone hydrochloride-oxycodone terephthalate combination | FAERS: 1 | US FAERS | |
| 6 | Erlotinib Hydrochloride | FAERS: 1 | US FAERS | |
| 7 | Everolimus | FAERS: 1 | US FAERS | |
| 8 | Fentanyl | FAERS: 1 | US FAERS | |
| 9 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 10 | dabrafenib | FAERS: 1 | US FAERS | |
| 11 | olaparib | FAERS: 1 | US FAERS | |
| 12 | pazopanib | FAERS: 1 | US FAERS | |
| 13 | Lactulose | OFFSIDES | ||
| 14 | Medroxyprogesterone Acetate | OFFSIDES | ||
| 15 | Medroxyprogesterone | OFFSIDES | ||
| 16 | Terbutaline | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.